Who is sponsoring NCT00503867?

NCT00503867 is sponsored by Sirtex Medical.

What condition does NCT00503867 study?

NCT00503867 studies Carcinoma, Hepatocellular, Hepatoma.

What drugs are being tested in NCT00503867?

Interventions: SIR-Spheres microspheres.

What is the status of NCT00503867?

NCT00503867 is currently TERMINATED.

Last reviewed 2020-12-10 · How we verify

SIR-Spheres® for the Treatment of Unresectable Hepatocellular Carcinoma

NCT00503867 NA TERMINATED Results posted

The main purpose of this study is to determine the safety and toxicity of treatment with SIR-Spheres® in patients with unresectable primary liver cancer or hepatocellular carcinoma (HCC). Other purposes of this study include assessment of the effect of treatment on overall survival, the length of time it takes for the disease to worsen, if and how the treatment affects the patient's quality of life, and if and how the cancer responds to the treatment.

Details

Lead sponsor	Sirtex Medical
Phase	NA
Status	TERMINATED
Enrolment	10
Start date	Wed Jul 18 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Tue Mar 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Carcinoma, Hepatocellular
Hepatoma

Interventions

SIR-Spheres microspheres

Countries

United States